JP2024519031A5 - - Google Patents
Info
- Publication number
- JP2024519031A5 JP2024519031A5 JP2023571272A JP2023571272A JP2024519031A5 JP 2024519031 A5 JP2024519031 A5 JP 2024519031A5 JP 2023571272 A JP2023571272 A JP 2023571272A JP 2023571272 A JP2023571272 A JP 2023571272A JP 2024519031 A5 JP2024519031 A5 JP 2024519031A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189503P | 2021-05-17 | 2021-05-17 | |
| US63/189,503 | 2021-05-17 | ||
| PCT/US2022/029533 WO2022245757A1 (en) | 2021-05-17 | 2022-05-17 | Compositions including conjugated therapy enhancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024519031A JP2024519031A (ja) | 2024-05-08 |
| JP2024519031A5 true JP2024519031A5 (https=) | 2025-05-23 |
| JPWO2022245757A5 JPWO2022245757A5 (https=) | 2025-05-23 |
Family
ID=84140038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571272A Pending JP2024519031A (ja) | 2021-05-17 | 2022-05-17 | コンジュゲート療法エンハンサーを含む組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240238436A1 (https=) |
| EP (1) | EP4351658A4 (https=) |
| JP (1) | JP2024519031A (https=) |
| KR (1) | KR20240012376A (https=) |
| CN (1) | CN117295527A (https=) |
| AU (1) | AU2022277840A1 (https=) |
| BR (1) | BR112023023506A2 (https=) |
| CA (1) | CA3219475A1 (https=) |
| IL (1) | IL307746A (https=) |
| MX (1) | MX2023013274A (https=) |
| PH (1) | PH12023553152A1 (https=) |
| WO (1) | WO2022245757A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX421628B (es) * | 2017-07-26 | 2025-03-14 | Kleo Pharmaceuticals Inc | Compuestos abt universales y usos de los mismos |
| US12364766B2 (en) * | 2018-04-09 | 2025-07-22 | Yale University | Bifunctional small molecules to target the selective degradation of circulating proteins |
| WO2019241609A1 (en) * | 2018-06-15 | 2019-12-19 | Trustees Of Boston University | Polypeptide compositions and methods for site-specific targeting of therapeutic agents |
| JP2023501720A (ja) * | 2019-11-18 | 2023-01-18 | クレオ ファーマシューティカルズ， インコーポレイテッド | 指向性コンジュゲーション技術 |
| JP2024509282A (ja) * | 2021-03-10 | 2024-02-29 | バイオヘイブン・セラピューティクス・リミテッド | ガラクトース欠損免疫グロブリンの二官能性分解剤 |
| US20240252674A1 (en) * | 2021-05-17 | 2024-08-01 | Biohaven Therapeutics Ltd. | Agents for directed conjugation techniques and conjugated products |
| CA3219550A1 (en) * | 2021-05-19 | 2022-11-24 | Gene M. Dubowchik | Antibody drug conjugates using mates technology for delivering cytotoxic agents |
| WO2023043861A2 (en) * | 2021-09-16 | 2023-03-23 | Biohaven Therapeutics Ltd. | Conjugated antibodies for treating diseases |
-
2022
- 2022-05-17 CA CA3219475A patent/CA3219475A1/en active Pending
- 2022-05-17 IL IL307746A patent/IL307746A/en unknown
- 2022-05-17 EP EP22805273.4A patent/EP4351658A4/en active Pending
- 2022-05-17 JP JP2023571272A patent/JP2024519031A/ja active Pending
- 2022-05-17 WO PCT/US2022/029533 patent/WO2022245757A1/en not_active Ceased
- 2022-05-17 KR KR1020237039153A patent/KR20240012376A/ko active Pending
- 2022-05-17 CN CN202280034211.XA patent/CN117295527A/zh active Pending
- 2022-05-17 PH PH1/2023/553152A patent/PH12023553152A1/en unknown
- 2022-05-17 BR BR112023023506A patent/BR112023023506A2/pt unknown
- 2022-05-17 MX MX2023013274A patent/MX2023013274A/es unknown
- 2022-05-17 US US18/555,855 patent/US20240238436A1/en active Pending
- 2022-05-17 AU AU2022277840A patent/AU2022277840A1/en active Pending